Table 1. Hyperthyroidism Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Hyperthyroidism Treatment Market Restraints

Table 3. Hyperthyroidism Treatment Market Trends

Table 4. Hyperthyroidism Treatment Industry Policy

Table 5. Global Hyperthyroidism Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Hyperthyroidism Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Hyperthyroidism Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Hyperthyroidism Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Hyperthyroidism Treatment Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Hyperthyroidism Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Hyperthyroidism Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Hyperthyroidism Treatment Manufacturers Product Type

Table 13. Head Office and Hyperthyroidism Treatment Production Site of Key Manufacturer

Table 14. Hyperthyroidism Treatment Capacity of Major Manufacturers and Future Plan

Table 15. China Hyperthyroidism Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Hyperthyroidism Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Hyperthyroidism Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Hyperthyroidism Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Hyperthyroidism Treatment Production by Region, 2018-2023, (K Units)

Table 20. Global Hyperthyroidism Treatment Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Hyperthyroidism Treatment Upstream (Raw Materials)

Table 22. Global Hyperthyroidism Treatment Typical Customers

Table 23. Hyperthyroidism Treatment Typical Distributors

Table 24. By Type, Global Hyperthyroidism Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Hyperthyroidism Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Hyperthyroidism Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Hyperthyroidism Treatment Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Hyperthyroidism Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Hyperthyroidism Treatment Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Hyperthyroidism Treatment Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Hyperthyroidism Treatment Sales Quantity Market Share, 2018-2029

Table 34. Merck Company Information, Head Office, Market Area, and Industry Position

Table 35. Merck Hyperthyroidism Treatment Models, Specifications, and Application

Table 36. Merck Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Merck Company Profile and Main Business

Table 38. Merck Recent Developments

Table 39. Herbrand PharmaChemicals Company Information, Head Office, Market Area, and Industry Position

Table 40. Herbrand PharmaChemicals Hyperthyroidism Treatment Models, Specifications, and Application

Table 41. Herbrand PharmaChemicals Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Herbrand PharmaChemicals Company Profile and Main Business

Table 43. Herbrand PharmaChemicals Recent Developments

Table 44. Shanghai Zhaohui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 45. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Models, Specifications, and Application

Table 46. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Shanghai Zhaohui Pharmaceutical Company Profile and Main Business

Table 48. Shanghai Zhaohui Pharmaceutical Recent Developments

Table 49. Beijing Yanjing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 50. Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Models, Specifications, and Application

Table 51. Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Beijing Yanjing Pharmaceutical Company Profile and Main Business

Table 53. Beijing Yanjing Pharmaceutical Recent Developments

Table 54. Jinghua Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 55. Jinghua Pharmaceutical Group Hyperthyroidism Treatment Models, Specifications, and Application

Table 56. Jinghua Pharmaceutical Group Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Jinghua Pharmaceutical Group Company Profile and Main Business

Table 58. Jinghua Pharmaceutical Group Recent Developments

Table 59. Guangzhou Kanghe Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 60. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Models, Specifications, and Application

Table 61. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Guangzhou Kanghe Pharmaceutical Company Profile and Main Business

Table 63. Guangzhou Kanghe Pharmaceutical Recent Developments

Table 64. Zigong Honghe Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 65. Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Models, Specifications, and Application

Table 66. Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Zigong Honghe Pharmaceutical Company Profile and Main Business

Table 68. Zigong Honghe Pharmaceutical Recent Developments

Table 69. Guangdong Huanan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 70. Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Models, Specifications, and Application

Table 71. Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Guangdong Huanan Pharmaceutical Company Profile and Main Business

Table 73. Guangdong Huanan Pharmaceutical Recent Developments

Table 74. Zibo Wankang Pharmaceutical Chemical Company Information, Head Office, Market Area, and Industry Position

Table 75. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Models, Specifications, and Application

Table 76. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Zibo Wankang Pharmaceutical Chemical Company Profile and Main Business

Table 78. Zibo Wankang Pharmaceutical Chemical Recent Developments

Table 79. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 80. Qilu Pharmaceutical Hyperthyroidism Treatment Models, Specifications, and Application

Table 81. Qilu Pharmaceutical Hyperthyroidism Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Qilu Pharmaceutical Company Profile and Main Business

Table 83. Qilu Pharmaceutical Recent Developments

List of Figures

Figure 1. Hyperthyroidism Treatment Picture

Figure 2. Global Hyperthyroidism Treatment Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Hyperthyroidism Treatment Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Hyperthyroidism Treatment Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Hyperthyroidism Treatment Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Hyperthyroidism Treatment Sales Quantity (K Units) & (2018-2029)

Figure 7. China Hyperthyroidism Treatment Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Hyperthyroidism Treatment Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Hyperthyroidism Treatment Market Share of Global, 2018-2029

Figure 10. Global Hyperthyroidism Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Hyperthyroidism Treatment Key Participants, Market Share, 2022

Figure 12. Global Hyperthyroidism Treatment Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Hyperthyroidism Treatment Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Hyperthyroidism Treatment Production Market Share & Forecast by Region, 2018-2029

Figure 15. Hyperthyroidism Treatment Industry Chain

Figure 16. Hyperthyroidism Treatment Procurement Model

Figure 17. Hyperthyroidism Treatment Sales Model

Figure 18. Hyperthyroidism Treatment Sales Channels, Direct Sales, and Distribution

Figure 19. Methimazole

Figure 20. Propylthiouracil

Figure 21. Other

Figure 22. By Type, Global Hyperthyroidism Treatment Consumption Value, 2018-2029, US$ Million

Figure 23. By Type, Global Hyperthyroidism Treatment Consumption Value Market Share, 2018-2029

Figure 24. By Type, Global Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 25. By Type, Global Hyperthyroidism Treatment Sales Quantity Market Share, 2018-2029

Figure 26. By Type, Global Hyperthyroidism Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 27. Hospital

Figure 28. Clinic

Figure 29. Other

Figure 30. By Application, Global Hyperthyroidism Treatment Consumption Value, 2018-2029, US$ Million

Figure 31. By Application, Global Hyperthyroidism Treatment Consumption Value Market Share, 2018-2029

Figure 32. By Application, Global Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 33. By Application, Global Hyperthyroidism Treatment Sales Quantity Market Share, 2018-2029

Figure 34. By Application, Global Hyperthyroidism Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 35. By Region, Global Hyperthyroidism Treatment Consumption Value Market Share, 2018-2029

Figure 36. By Region, Global Hyperthyroidism Treatment Sales Quantity Market Share, 2018-2029

Figure 37. North America Hyperthyroidism Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 38. By Country, North America Hyperthyroidism Treatment Consumption Value Market Share, 2022

Figure 39. Europe Hyperthyroidism Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, Europe Hyperthyroidism Treatment Consumption Value Market Share, 2022

Figure 41. Asia Pacific Hyperthyroidism Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country/Region, Asia Pacific Hyperthyroidism Treatment Consumption Value Market Share, 2022

Figure 43. South America Hyperthyroidism Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, South America Hyperthyroidism Treatment Consumption Value Market Share, 2022

Figure 45. Middle East & Africa Hyperthyroidism Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 46. U.S. Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 47. By Type, U.S. Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 48. By Application, U.S. Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 49. Europe Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 50. By Type, Europe Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 51. By Application, Europe Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 52. China Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 53. By Type, China Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 54. By Application, China Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 55. Japan Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 56. By Type, Japan Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 57. By Application, Japan Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 58. South Korea Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 59. By Type, South Korea Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 60. By Application, South Korea Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 61. Southeast Asia Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 62. By Type, Southeast Asia Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 63. By Application, Southeast Asia Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 64. India Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 65. By Type, India Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 66. By Application, India Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 67. Middle East & Africa Hyperthyroidism Treatment Sales Quantity, 2018-2029, (K Units)

Figure 68. By Type, Middle East & Africa Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 69. By Application, Middle East & Africa Hyperthyroidism Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up and Top-down Approaches

Figure 73. Top-down Approaches